ANI Pharmaceuticals (ANIP) Insider Trading & Ownership $62.56 +0.44 (+0.71%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$62.47 -0.09 (-0.14%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANI Pharmaceuticals (NASDAQ:ANIP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$7.04M Get ANIP Insider Trade Alerts Want to know when executives and insiders are buying or selling ANI Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ANIP Insider Buying and Selling by Quarter ANI Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/15/2025Ori GutwergSVPSell881$60.07$52,921.67 5/14/2025Christopher MutzInsiderSell4,000$60.45$241,800.00 4/14/2025Meredith CookVPSell400$68.96$27,584.00 3/13/2025Meredith CookVPSell400$63.33$25,332.00 3/7/2025Krista DavisSVPSell1,000$60.86$60,860.00 2/21/2025Krista DavisSVPSell1,000$60.20$60,200.00 2/13/2025Meredith CookVPSell400$59.54$23,816.00 1/13/2025Meredith CookVPSell400$53.92$21,568.00 12/17/2024Stephen P CareyCFOSell7,500$55.79$418,425.00 12/11/2024Krista DavisSVPSell1,000$60.00$60,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/26/2024Nikhil LalwaniCEOSell33,481$57.99$1,941,563.19 10/14/2024Meredith CookVPSell250$57.19$14,297.50 9/13/2024Meredith CookVPSell250$56.82$14,205.00 8/13/2024Meredith CookVPSell250$59.62$14,905.00 7/17/2024Muthusamy ShanmugamCOOSell14,257$63.16$900,472.12 7/15/2024Muthusamy ShanmugamCOOSell11,000$63.38$697,180.00 7/12/2024Meredith CookVPSell250$64.91$16,227.50 7/1/2024Chad GassertSVPSell20,000$63.44$1,268,800.00 6/21/2024Muthusamy ShanmugamCOOSell20,000$58.90$1,178,000.00 (Data available from 1/1/2013 forward) ANIP Insider Trading Activity - Frequently Asked Questions Who is on ANI Pharmaceuticals's Insider Roster? The list of insiders at ANI Pharmaceuticals includes Antonio R Pera, Chad Gassert, Christopher Mutz, James G Marken, Krista Davis, Meredith Cook, Meridian Venture Partners Ii L, Muthusamy Shanmugam, Nikhil Lalwani, Ori Gutwerg, Renee P Tannenbaum, and Stephen P Carey. Learn more on insiders at ANIP. What percentage of ANI Pharmaceuticals stock is owned by insiders? 12.70% of ANI Pharmaceuticals stock is owned by insiders. Learn more on ANIP's insider holdings. Which ANI Pharmaceuticals insiders have been selling company stock? The following insiders have sold ANIP shares in the last 24 months: Antonio R Pera ($181,110.00), Chad Gassert ($10,774,200.00), Christopher Mutz ($365,020.00), James G Marken ($1,615,313.06), Krista Davis ($322,149.82), Meredith Cook ($248,175.00), Meridian Venture Partners Ii L ($11,700,000.00), Muthusamy Shanmugam ($22,741,366.05), Nikhil Lalwani ($10,017,400.43), Ori Gutwerg ($1,223,767.46), Renee P Tannenbaum ($127,740.00), and Stephen P Carey ($1,246,762.85). How much insider selling is happening at ANI Pharmaceuticals? Insiders have sold a total of 1,014,457 ANI Pharmaceuticals shares in the last 24 months for a total of $60,563,004.67 sold. ANI Pharmaceuticals Key ExecutivesMr. Nikhil Lalwani (Age 46)President, CEO & Director Compensation: $2.32MMr. Stephen P. Carey (Age 53)Senior VP of Finance & CFO Compensation: $1.11M1 recent tradesMr. Chad Gassert (Age 48)Senior Vice President of Corporate Development & Strategy Compensation: $849.71kMr. Christopher K. Mutz (Age 52)Senior Vp & Head of Rare Disease Compensation: $867.92k1 recent tradesMr. Ori Gutwerg (Age 49)Senior Vice President of Generics Compensation: $895.16k1 recent tradesMr. Muthusamy Shanmugam MS R.Ph. (Age 56)Head of R&D, COO of Novitium Operations & Director Mr. James G. Marken (Age 61)Senior Vice President of Operations Compensation: $673.23kMs. Elizabeth Powell J.D.Chief Compliance Officer & Head of Legal of Rare DiseaseMs. Meredith W. Cook (Age 49)Senior VP, General Counsel & Corporate Secretary 4 recent tradesMs. Krista L. Davis (Age 50)Senior VP & Chief Human Resources Officer 2 recent trades More Insider Trading Tools from MarketBeat Related Companies Nuvalent Insider Trades Axsome Therapeutics Insider Trades ADMA Biologics Insider Trades Vaxcyte Insider Trades Akero Therapeutics Insider Trades Rhythm Pharmaceuticals Insider Trades Zai Lab Insider Trades PTC Therapeutics Insider Trades Cytokinetics Insider Trades Avidity Biosciences Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:ANIP) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
